AGP Picks
View all

The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

Press releases published on November 6, 2026

Arch Biopartners Arranges Non-Brokered Private Placement
Treace Medical Concepts Reports Third Quarter 2026 Financial Results
Anika Reports Third Quarter 2026 Financial Results
Treace Announces First Surgical Cases with the Tailorplasty™ MIS Tailor’s Bunion Correction System
What Do Healthcare Sharing Programs Actually Cover, and What They Don’t
Satellos Changes Primary Efficacy Endpoint in BASECAMP Phase 2 Pediatric Trial to MRI-Measured Fat Fraction Following FDA Feedback
Korro to Present at the 2026 Jefferies Global Healthcare Conference in London
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fractyl Health to Report Third Quarter 2026 Financial Results and Provide Business Updates on November 12, 2026
EyePoint Announces Participation at Upcoming Investor Conferences and Scientific Meetings
Spectral Medical Announces Third Quarter 2026 Financial Results and Provides Corporate Update
Eccogene to Present Preclinical Data of Small Molecule Amylin and Calcitonin Receptor Agonist ECC1542 at ObesityWeek® 2026
Fennec Pharmaceuticals to Report Third Quarter 2026 Financial Results on November 12, 2026
Groundbreaking therapy for advanced heart failure: Repairon’s Scientific Co-Founder, Prof. Wolfram-Hubertus Zimmermann, Receives the 2026 “Galenus-von-Pergamon” Award for Outstanding Basic Pharmacological Research
Nature Medicine Publication Reveals How Human Movement Predicts Hidden Biosignals Spanning 18 Body Systems, from Heart and Liver Function to Metabolic and Mental Health
Nxera Pharma Announces Vamorolone Selected for South Korea’s Accelerated Reimbursement Pilot Program for Rare Disease Treatments
Ultragenyx Announces the Marketing Authorisation Application (MAA) for its Investigational Gene Therapy for MPS IIIA (Sanfilippo syndrome Type A) is Under Review with the UK Medicines and Healthcare Products Regulatory Agency (MHRA)
Newsweek zählt das KFSH in Riad zu den besten 5 % der weltweit führenden Krankenhäuser und Kliniken für Medizintourismus im Jahr 2027
Le KFSH de Riyad figure parmi les 5 % des meilleurs établissements de santé au monde pour le tourisme médical selon le classement 2027 de Newsweek
MHRA approves Pharming’s Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The Georgian Health Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.